Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 955

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9A
Chunk 955
---
 pursuant to Section 302 of Sarbanes-Oxley Act of 2002

    32.1*
     
    Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002

    32.2*
     
    Certification of Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002

    97.1
     
    Clawback Policy (incorporated by reference as Exhibit 97.1 to the Registrant’s Annual Report on Form 10-K filed with the SEC on April 1, 2024)

    101.INS
     
    Inline
    XBRL Instance Document

    101.SCH
     
    Inline
    XBRL Taxonomy Extension Schema Document

    101.CAL
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase Document

    101.DEF
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase Document

    101.LAB
     
    Inline
    XBRL Taxonomy Extension Label Linkbase Document

    101.PRE
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase Document

    104
     
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)

    *
    Filed
    herewith.
  
    +
    Indicates
    management contract or compensatory plan.

 69 

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized on the 31st day of March, 2025.

    bioAffinity
    Technologies, Inc.

    By:
    /s/
    Maria Zannes

    Maria
    Zannes

    Chief
    Executive Officer, President, and Director

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/
    Maria Zannes
     
    President,
    Chief Executive Officer, and Director
    (Principal
    Executive Officer)
     
    March
    31, 202